Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 30 results found. Search for [ Regeneron ]

Results 1 to 21 of 30
Reuters
November 22, 2020
The agency said the antibodies are not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19


Reuters
November 11, 2020
The Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Eli Lilly & Co's bamlanivimab based on trial data


PTI
October 31, 2020
Responding to a complaint by RTI activist Saket Gokhale, the commission said it has found no violation of the provisions of the model code in the issue


PTI
October 31, 2020
Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients


BusinessToday.In
October 30, 2020
The company said that it has been listed ahead of global pharma companies such as Roche, Eli Lilly, Abbott, Novartis, and Pfizer in this year's rankings


Reuters
October 27, 2020
President Donald Trump received a similar experimental antibody drug from Regeneron Pharmaceuticals Inc on an emergency basis when he was sickened with the coronavirus earlier this month


Reuters
October 16, 2020
The American company said the data appeared inconsistent, the findings were premature and that other studies had validated the drug's benefits


PTI
October 14, 2020
Trump, who tested positive for COVID-19 on October 1 and was admitted to a military hospital for three nights and four days, declared himself cured after he was treated with an experimental antibody drug cocktail


BusinessToday.In
October 14, 2020
Dr Reddy's has teamed up with Russian Development Investment Fund (RDIF) to conduct trials and distribute 100 million doses of Sputnik V in India


Reuters
October 14, 2020
Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc that he received for his COVID-19, as tantamount to a cure in a video he posted last week


BusinessToday.In
October 13, 2020
Scientists from the University of Toronto and the Lunenfeld-Tanenbaum Research Institute at Sinai Health used both blood samples and saliva from coronavirus patients to assess and compare antibody levels for over three months post the onset of the first symptom


BusinessToday.In
New Delhi, October 13, 2020
President Trump, in another address, hailed the experimental antiviral cocktail made by Regeneron, the treatment which was administered to him. He praised the cocktail treatment even though the effectiveness and safety of the drug are yet to be proved. He also said his diagnosis was 'a blessing in disguise' in the nation's battle against the pandemic. Watch the full speech for more.


Reuters
October 10, 2020
The agreement, under the Trump administration's Operation Warp Speed, is for developing a monoclonal antibody cocktail that can prevent COVID-19


BusinessToday.In
October 8, 2020
Donald Trump, who was admitted at Walter Reed National Military Medical centre on Friday, had received \"a single 8-gram dose\" of Regeneron's monoclonal antibody cocktail


PTI
October 8, 2020
Trump was admitted to Walter Reed National Medical Center last Friday, a day after he and First Lady Melania Trump tested positive for COVID-19


Associated Press
October 4, 2020
Donald Trump offered his own assessment of his status Saturday evening in a video from his hospital suite, saying he was beginning to feel better and hoped to \"be back soon.\"


Reuters
August 18, 2020
The French group already owns the licensing rights to Principia's key multiple sclerosis drugs, which should give it a clearer view on its prospects


PTI
August 17, 2020
Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with the Russian Direct Investment Fund (RDIF)


Reuters
August 7, 2020
The latest contract is priced at roughly $10 per vaccine dose produced by J&J, or around $14.50 per dose, including a previous $456 million the U.S. government promised to J&J for vaccine development in March


Reuters
August 4, 2020
The Phase III trial is expected to enroll up to 2,400 participants who live or work at facilities that have had a recently diagnosed case of COVID-19


PAGES 1 OF 2  12